Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)]
- RabMAb
- Recombinant
- What is this?
3
(6 Reviews)
|
(40 Publications)
Rabbit Recombinant Monoclonal GDF11 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Rat, Human samples. Cited in 40 publications.
View Alternative Names
BMP11, GDF11, Growth/differentiation factor 11, GDF-11, Bone morphogenetic protein 11, BMP-11
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)] (AB124721)
Immunocytochemistry/Immunofluorescence analysis of A549 cells labelling BMP11 + GDF8/Myostatin with purified ab124721 at 1/250. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% triton X-100. ab150078, an Alexa Fluor® 555-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain.
Control : primary antibody (1/250) and secondary antibody, ab150113, an Alexa Fluor® 488-conjugated goat anti-mouse IgG (1/500).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)] (AB124721)
ab124721 staining GDF11 + GDF8/Myostatin in the human cell line HeLa (human cervix adenocarcinoma) by intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde, permabilised with 90% methanol and the sample was incubated with the primary antibody at a dilution of 1/250. A goat anti rabbit IgG (Alexa Fluor® 488) at a dilution of 1/2000 was used as the secondary antibody.
Isoytype control : Rabbit monoclonal IgG (Black)
Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue)
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)] (AB124721)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon adenocarcinoma tissue labelling BMP11 + GDF8/Myostatin with unpurified ab124721 at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)] (AB124721)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cerebral cortex tissue labelling BMP11 + GDF8/Myostatin with purified ab124721 at 1/2500. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. A prediluted HRP-polymer conjugated anti-rabbit IgG was used as the secondary antibody. Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- WB
Supplier Data
Western blot - Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)] (AB124721)
Blocking and diluting buffer : 5% NFDM/TBST This antibody is unsuitable to detect tissue samples.
All lanes:
Western blot - Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)] (ab124721) at 1/1000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
C2C12 (Mouse myoblasts myoblast) whole cell lysate at 20 µg
Lane 4:
C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
Lane 5:
Rat liver lysate at 20 µg
Lane 6:
Rat heart lysate at 20 µg
Lane 7:
Rat kidney lysate at 20 µg
Lane 8:
Mouse brain lysate at 20 µg
Lane 9:
Mouse liver lysate at 20 µg
Lane 10:
Human liver lysate at 20 µg
Lane 11:
Human skeletal muscle lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 45 kDa
false
Exposure time: 5s
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-GDF11 + GDF8/Myostatin antibody [EPR4567(2)] (AB124721)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (40)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed40332596
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:7476 PubMed37978295
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 238:2827-2840 PubMed37801347
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of endocrinology 2023:9926462 PubMed37584041
2023
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 11:e15756 PubMed37332022
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 14:1137048 PubMed37033257
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bone & joint research 11:453-464 PubMed35787089
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 20:101398 PubMed35339890
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:774185 PubMed35155444
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in bioengineering and biotechnology 9:803052 PubMed35059389
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com